Abbott Laboratories Statistics
Total Valuation
BCBA:ABT has a market cap or net worth of ARS 274.56 trillion. The enterprise value is 282.37 trillion.
| Market Cap | 274.56T |
| Enterprise Value | 282.37T |
Important Dates
The last earnings date was Thursday, January 22, 2026.
| Earnings Date | Jan 22, 2026 |
| Ex-Dividend Date | Jan 15, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 80.65% |
| Float | 1.73B |
Valuation Ratios
The trailing PE ratio is 29.00 and the forward PE ratio is 19.66.
| PE Ratio | 29.00 |
| Forward PE | 19.66 |
| PS Ratio | 4.27 |
| PB Ratio | 3.69 |
| P/TBV Ratio | 8.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 29.82 |
| EV / Sales | 4.53 |
| EV / EBITDA | 17.47 |
| EV / EBIT | 23.92 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | n/a |
| Interest Coverage | 45.37 |
Financial Efficiency
Return on equity (ROE) is 13.16% and return on invested capital (ROIC) is 11.45%.
| Return on Equity (ROE) | 13.16% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.45% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 564.37M |
| Profits Per Employee | 83.06M |
| Employee Count | 115,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BCBA:ABT has paid 2.82 trillion in taxes.
| Income Tax | 2.82T |
| Effective Tax Rate | 22.94% |
Stock Price Statistics
The stock price has increased by +5.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +5.86% |
| 50-Day Moving Average | 45,932.80 |
| 200-Day Moving Average | 44,365.05 |
| Relative Strength Index (RSI) | 31.92 |
| Average Volume (20 Days) | 3,593 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.29 |
Income Statement
In the last 12 months, BCBA:ABT had revenue of ARS 64.34 trillion and earned 9.47 trillion in profits. Earnings per share was 5,399.21.
| Revenue | 64.34T |
| Gross Profit | 36.49T |
| Operating Income | 12.18T |
| Pretax Income | 12.29T |
| Net Income | 9.47T |
| EBITDA | 16.68T |
| EBIT | 12.18T |
| Earnings Per Share (EPS) | 5,399.21 |
Balance Sheet
The company has 11.22 trillion in cash and 18.83 trillion in debt, with a net cash position of -7,608.24 billion.
| Cash & Cash Equivalents | 11.22T |
| Total Debt | 18.83T |
| Net Cash | -7,608.24B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 74.40T |
| Book Value Per Share | 42,530.24 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.71%, with operating and profit margins of 18.94% and 14.72%.
| Gross Margin | 56.71% |
| Operating Margin | 18.94% |
| Pretax Margin | 19.10% |
| Profit Margin | 14.72% |
| EBITDA Margin | 25.93% |
| EBIT Margin | 18.94% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 583.94, which amounts to a dividend yield of 1.43%.
| Dividend Per Share | 583.94 |
| Dividend Yield | 1.43% |
| Dividend Growth (YoY) | 73.09% |
| Years of Dividend Growth | 12 |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | 1.37% |
| Earnings Yield | 3.45% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Oct 22, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |